Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Benvenue Medical said it put a bow around a $60 million funding round for its Luna and Kiva treatments for degenerative disc disease and vertebral compression fractures.
The round consists of $23 million in equity and another $37 million in debt, Benvenue said, with DeNovo Ventures, Domain Associates, Esquilime Partners, InterWest Partners, Technology Partners and Versant Ventures participating in the equity sale. CRG, which alone bought into the debt portion, also got in on the equity sale, Benvenue said. Read more
Insulet said that it’s launching a new data system for its OmniPod device that uses Glooko’s diabetes management platform.
Medtronic-backed Glooko’s platform is designed to integrate data from blood glucose monitors and other devices with either an Apple iPhone or Google Android application. Food intake, medication and insulin dosage can also be recorded to provide context for changes in blood glucose readings. Data from meters and devices is sent to Glooko’s cloud-based Population Tracker, where patients and providers alike can view and analyze the data, and make decisions about interventions and treatments. Read more
NuVasive Inc. and Ellipse Technologies said yesterday that they inked a deal worth up to $410 million for NuVasive to acquire Ellipse and its adjustable orthopedic implants.
Aliso Viejo, Calif.-based Ellipse, which registered a $75 million initial public offering last October, has a pair of orthopedic surgery devices already on the market: The Magec-Eos spinal bracing and distraction system for early-onset scoliosis, and the Precice limb-lenthening systemfor treating limb length discrepancies. Read more